30 closest matches · ranked by relevance
Electronic Nicotine Delivery System Flavors
Primary: Average Daily Cigarette Use — 10.3; 17.3; 12.3; 5.3 number of cigarettes per day
Nicotine Dependence
Primary: The Reinforcing Drug Effects Will be Measured With the Drug Effects Questionnaire (DEQ). — 43.18; 26.22; 25.20; 56.00 units on a scale
Nicotine Dependence
Primary: Changes in Liking of E-cigarette Overall — 14.2; 5.3; 11.9; 2.2 score on a scale — p=0.01
Cigarette Smoking Behavior
Primary: Nicotine/Tobacco Products Substitution — 1326.25; 206; 120.83; 46.79 mg of nicotine purchased
Tobacco Use
Primary: Number of Cigarettes Purchased — 154.7; 119.2 average number of cigarettes
Electronic Cigarette Use
Primary: Intensity of Drug Purchase Task (DPT) — 172.20; 89.90; 60.83; 94.50 number of puffs
Nicotine Use Disorder
Primary: Liking: Difference Score in Liking/Wanting of Each E-cigarette Condition — 1.268; -3.916 score on a scale — p=0.053
Nicotine Use Disorder
Primary: Change Score in Liking/Wanting of E-cigarette — -1.06; -5.59; -7.14; -7.63 units on scale
Tobacco Dependence
Primary: Baseline Neural Flavor Cue-reactivity at Baseline — 0.08; 0.23; 0.10; 0.14 percentage of BOLD signal change
E-cigarette Use
Primary: Plasma Nicotine Concentration — 0.78; 1.08; 0.89; 1.16 ng/ml
Tobacco Use Disorder
Primary: Spent the Budget on E-cigarettes for Each Condition — 10.64; 14.87; 14.74; 14.65 percentage of spent budget
Health Behavior
Primary: Effects E-cig Use on Venous Nicotine Concentrations Before and 5 Minutes After Use — 4.30; 4.11; 8.66; 8.77 ng/ml
Nicotine Vaping
Primary: Change in Maximum Arterial Blood Nicotine Delivery (Cmax) — 3.75; 2.48; 8.12; 2.96 ng/ml
Tobacco Use Disorder
Primary: Questionnaire Scale "Intentions for Future Use" — 3.1; 3.7 units on a scale
Electronic Cigarette Use
Primary: Plasma Nicotine Concentration — 2.00; 1.92; 1.64; 1.62 mg/ml
Tobacco Use Disorder
Primary: Number of Cigarettes Smoked Per Day — 2.2; 1.8; 6.0; 7.1 model estimated cigarettes per day
Nicotine · Nicotine Vaping · E-cigarette Use
Primary: Behavioral Intentions for Continued Use — 3.73; 3.88; 3.91; 3.74 score on a scale
Electronic Cigarettes
Primary: Plasma Nicotine Concentration — 12.32; -0.22; 7.09; 5.85 ng/ml
Vaping Behavior
Primary: Intentions of Using the E-cigarette — 5.27; 5.56; 5.52; 5.70 score on a scale
Smoking
Primary: Total Cigarettes Smoked Per Day — 21.6; 7.7; 18.4; 12.5 number of cigarettes
Nicotine Dependence
Primary: Drug Effects Questionnaire (DEQ)- 'Good Drug Effects' — 5.1979; 6.8384; 5.6235; 7.6285 scores on a scale — p=<.0001
Cigarette Smoking · Vaping
Primary: Total Amount of Combusted Tobacco Purchased — 990.6 mg
Nicotine Dependence · Smoking Cessation
Primary: Sustained 50% Reduction in the Number of Cig/Day at Week-24 From Baseline (Reducers) — 13 number of participants
Healthy Volunteers
Primary: Nicotine Plasma Concentration — 3.6; 2.5; 2.5; 21.2 ng/ml
Smoking, Cigarette · Electronic Cigarettes
Primary: Number of Cigarette Puffs Taken (0 to 20) — 12.1; 10.8 Puffs chosen
Smoking
Primary: Cigarette Use — -1.82 cigarettes
Cigarette Smoking-Related Carcinoma
Primary: PET/CT Imaging of the Head — 2.81; 2.40 %TAD/kg
Nicotine Dependence
Primary: Standardized Session: Mean CMax — 6.1; 20.2 ng/mL
Tobacco Use Disorder
Primary: Amount of Tobacco Product Used — 13.1; 18.6; 15.3; 56.7 tobacco products use per day — p=0.349
Tobacco Dependence
Primary: Urinary NNAL (4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol) — 505.6; 459.1; 373.3; 180.5 pg/mg creatinine — p=0.017